INTRODUCTION

Toxoplasma gondii infection can be diagnosed directly by polymerase chain reaction (PCR), hybridization and isolation of parasites and indirectly with serological methods
. Although [10; 16; 17; 3] . In this context, the Toxoplasma gondii matrix antigen 1 (TgMAG1) known as 65-kDa protein abundantly expressed within the cyst and in the cyst wall surrounding the bradyzoites [15] , has documented to be immunogenic during the infection with T.gondii in mouse model and promising reagent for serodiagnosis of toxoplasmosis in humans [15; 12; 6] . However, its usefulness has not yet been confirmed in animal toxoplasmosis. In this study, the optimization and validation of E.coli-expressed rTgMAG1 as ELISA antigen were described.
MATERIALS AND METHODS
Parasite culture and purification
In this study, Toxoplasma gondii RH and PLK strains, and N. caninum Nc-1 strain were cultivated in Vero cells, and purified.
Expression and purification of recombinant TgMAG1
In this study, recombinant TgMAG1 was expressed as the glutathione S-transferase (GST)-fusion protein.
The protein was purified using glutathioneSepharose 4B beads (Amersham Pharmacia Biotech, USA). After dialysis and filtration, the purity and quality of purified protein were estimated by SDS-PAGE.
ELISA
Ninety-six-well plates (Nunc, Denmark) were coated with rTgMAG1 (1 μg/ml) and GST (1 μg/ml) diluted in the antigen coating buffer (0.05 M carbonate buffer, pH 9.6) at 4 º C overnight. The plates were washed with washing solution (PBS containing 0.05% Tween 20) and then the wells were blocked with blocking solution (PBS containing 3% skim milk) at 37 º C for 1 hr. After discarding the blocking solution the wells were incubated with the test sera 
Experimental infection of mice
Eight-week-old female mice (ICR strain; n=10/group) were intraperitoneally inoculated with either T.gondii PLK strain (400 tachyzoites/mouse) or N.caninum Nc-1 strain (40,000 tachyzoites/mouse) with 0.2 ml of MEM. The blood samples were serially collected once a week from tail bleeds using capillary hematocrit tubes (Hirschmann Laborgerate, Germany). The mice were housed in a P2 level facility, and the experiments were conducted in accordance with the Stipulated Regulations for the Care and Use of Research Animals promulgated by the Obihiro University of Agriculture and Veterinary Medicine.
RESULTS
The rTgMAG1 was expressed as the GST-fusion protein with a molecular mass of 91 kDa. Sera from mice experimentally infected with T.gondii PLK strain specifically reacted with the recombinant TgMAG1 but not with GST protein by Western blot analysis, suggesting that rTgMAG1 has good antigenicity for detecting a specific antibody to T.gondii. The anti-rTgMAG1 serum produced in mice did not cross-react with N.caninum and specifically recognized 65 kDa protein on the T.gondii lysate by Western blot analysis. The potential of the recombinant protein as a diagnostic antigen was then evaluated in an ELISA using sera from mice experimentally infected with T.gondii and N. caninum. Consisting with results of Western blot analysis, sera from mice infected with T.gondii (2 months post-infection) demonstrated strong reactivity (optical density, >0.1), contrary to sera from either mice experimentally infected with N.caninum or non-uninfected mice that showed very low OD values (Fig. 1) . Furthermore, the sensitivity of rTgMAG1 was evaluated in ELISA with sera collected serially from experimentally T.gondiiinfected mice. As shown in Figure 2 , the antibody responses to rTgMAG1 were detected in serial serum samples as early as the second week postinfection and maintained in a high level until 24 weeks post-infection, indicating that the ELISA with rTgMAG1 could detect antibodies to T.gondii in both acute and chronic stages. These data suggest the successful optimization and standardization of ELISA using rTgMAG1 for detection of T. gondii infection.
DISCUSSION
The detection of T.gondii infection with high sensitivity and specificity is crucial in the management of the disease. Toxoplasmosis is generally diagnosed by demonstrating specific antibodies to T.gondii antigens in the patient's serum sample. Most of the commercially available tests use T.gondii native antigens and display wide variations in test accuracy. A large number of different recombinant antigens were produced in E.coli and studied for their potential to serve as diagnostic reagents for detection of T.gondii infection in human and animals; these included dense granule proteins GRA1, GRA2, GRA4, GRA6, GRA7, GRA8; surface antigen SAG1 and SAG2; rhoptry antigens ROP1 and ROP2; microneme proteins MIC3 and MIC5 [14; 11; 19; 8; 10; 1; 2] . Although this approach would allow detection on antibody to a single protein of the parasites, the high productivity and purity of recombinant proteins coupled with specificity suggest their potential as replacements for tachyzoite materials in serodiagnosis. Despite the potential advantages of these recombinant antigens in serodiagnosis, only few commercial diagnostic kits are based on recombinant antigens. Thus, the discovery of new infection markers and development of improved diagnostic assays using recombinant antigens are needed [9] . The sufficient production of recombinant TgMAG1 expressed in E.coli as GST-fusion protein and its high immunological activity with infected sera were promising to develop an ELISA based on rTgMAG1 to detect an antibody to T.gondii infection in mouse models. The rTgMAG1 reacted with sera from mice experimentally infected with T.gondii, and showed significantly higher OD values than those from N.caninum-infected or non-infected mice, which reveals the success of ELISA as a tool for detection of infection. Next, the sensitivity of the test was evaluated with mice experimentally infected with T.gondii. The detectable antibody responses to rTgMAG1 were observed as early as the second week post-infection and maintained these responses until 24 weeks post-infection. No significant difference in OD values between sera collected from acute and chronic infection stages. These results indicated that the ELISA with rTgMAG1 could detect antibodies to T.gondii in both acute and chronic infection stages. However, rTgMAG1 was initially reported to be expressed specifically during bradyzoite development and localized to the ground substance of the tissue cyst; but it was subsequently reported that MAG1 was expressed during both tachyzoite and bradyzoite development stages and is not a bradyzoite-specific protein [13; 7] . On the other hand, it was found that IgG reactivity to rTgMAG1 could be highly detected in acute infection [6] . Pfrepper et al. [17] reported that rTgMAG1 was weakly reactive in acute and highly reactive in chronic infection. The variations in these results may be due to the differences of the protein fragment, expression system and serum samples studied. However, in this study rTgMAG1 has shown high reactivity with sera from both acutely and chronically T.gondii-infected mice. Taken together, these data coupled with the unique characteristics of TgMAG1 being an immunogenic and conserved protein among different strains suggest that the ELISA using rTgMAG1 is promising tool for detection of infection and can be further used for routine test or for screening a mass of samples to detect the presence of antibody for toxoplasmosis.
SUMMARY
Toxoplasma gondii matrix antigen 1 (TgMAG1), known as the 65 kDa protein that abundantly expressed in both bradyzoites and tachyzoites, was evaluated as a candidate for the development of a diagnostic reagent in mouse models. The ELISA with rTgMAG1 showed a highly specific reaction with sera from mice experimentally infected with T.gondii but not with the closely related Neospora caninum. Moreover, the antibodies to rTgMAG1 were detectable from the acute to the chronic infection stages. These results suggest that rTgMAG1 could be used as a reliable antigen for the detection of T.gondii infection in other animals. 
